Literature DB >> 17031832

Correlation between dynamic susceptibility contrast perfusion MRI and methionine metabolism in brain gliomas: preliminary results.

Niloufar Sadeghi1, Isabelle Salmon, Bich Ngoc Thanh Tang, Vincent Denolin, Marc Levivier, David Wikler, Sandrine Rorive, Danielle Balériaux, Thierry Metens, Serge Goldman.   

Abstract

PURPOSE: To evaluate in brain gliomas the relationship between tumor vascularity measured by MR-based maximum regional cerebral blood volume (rCBV) and tumor amino-acid metabolism based on maximum carbon-11 methionine (MET) uptake on positron emission tomography (PET).
MATERIALS AND METHODS: Eighteen patients with histologically proven primary brain gliomas were included in the study. In addition to conventional MR sequences, dynamic MR images, including a first-pass gadopentetate dimeglumine T2*-weighted echo-planar perfusion sequence and a PET study using MET, were acquired. Eleven patients had low-grade gliomas, and seven had high-grade gliomas. rCBV ratios and MET uptake ratios normalized to the contralateral white matter (WM) corresponding values were measured in each tumor. Both maximum rCBV ratios and maximum MET uptake ratios were correlated to histopathology. The maximum rCBV ratios were correlated to the maximum MET uptake ratios.
RESULTS: Both the maximum rCBV ratios and maximum MET uptake ratios of high-grade gliomas were significantly higher than those of low-grade gliomas (P<0.05). There was a significant positive correlation between maximum rCBV ratios and maximum MET uptake ratios (Spearman: r=0.89, P<0.00001).
CONCLUSION: The maximum rCBV ratio and maximum MET uptake ratio are significantly correlated in gliomas, reflecting a close link between amino acid uptake and vascularity in these tumors. Copyright (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17031832     DOI: 10.1002/jmri.20757

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  17 in total

Review 1.  Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.

Authors:  Nathalie L Albert; Michael Weller; Bogdana Suchorska; Norbert Galldiks; Riccardo Soffietti; Michelle M Kim; Christian la Fougère; Whitney Pope; Ian Law; Javier Arbizu; Marc C Chamberlain; Michael Vogelbaum; Ben M Ellingson; Joerg C Tonn
Journal:  Neuro Oncol       Date:  2016-04-21       Impact factor: 12.300

Review 2.  Clinical Imaging for Diagnostic Challenges in the Management of Gliomas: A Review.

Authors:  Alipi V Bonm; Reed Ritterbusch; Patrick Throckmorton; Jerome J Graber
Journal:  J Neuroimaging       Date:  2020-01-10       Impact factor: 2.486

Review 3.  Discrimination between primary low-grade and high-grade glioma with 11C-methionine PET: a bivariate diagnostic test accuracy meta-analysis.

Authors:  Anna Falk Delgado; Alberto Falk Delgado
Journal:  Br J Radiol       Date:  2018-01-22       Impact factor: 3.039

Review 4.  Imaging biomarkers of angiogenesis and the microvascular environment in cerebral tumours.

Authors:  G Thompson; S J Mills; D J Coope; J P B O'Connor; A Jackson
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

5.  Whole-tumor histogram analysis of the cerebral blood volume map: tumor volume defined by 11C-methionine positron emission tomography image improves the diagnostic accuracy of cerebral glioma grading.

Authors:  Rongli Wu; Yoshiyuki Watanabe; Atsuko Arisawa; Hiroto Takahashi; Hisashi Tanaka; Yasunori Fujimoto; Tadashi Watabe; Kayako Isohashi; Jun Hatazawa; Noriyuki Tomiyama
Journal:  Jpn J Radiol       Date:  2017-09-06       Impact factor: 2.374

Review 6.  Value of 11C-methionine PET in imaging brain tumours and metastases.

Authors:  Andor W J M Glaudemans; Roelien H Enting; Mart A A M Heesters; Rudi A J O Dierckx; Ronald W J van Rheenen; Annemiek M E Walenkamp; Riemer H J A Slart
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-12-12       Impact factor: 9.236

7.  Increased tryptophan transport in epileptogenic dysembryoplastic neuroepithelial tumors.

Authors:  Bálint Alkonyi; Sandeep Mittal; Ian Zitron; Diane C Chugani; William J Kupsky; Otto Muzik; Harry T Chugani; Sandeep Sood; Csaba Juhász
Journal:  J Neurooncol       Date:  2011-11-03       Impact factor: 4.130

8.  Intra-lesional spatial correlation of static and dynamic FET-PET parameters with MRI-based cerebral blood volume in patients with untreated glioma.

Authors:  Jens Göttler; Mathias Lukas; Anne Kluge; Stephan Kaczmarz; Jens Gempt; Florian Ringel; Mona Mustafa; Bernhard Meyer; Claus Zimmer; Markus Schwaiger; Stefan Förster; Christine Preibisch; Thomas Pyka
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-12-02       Impact factor: 9.236

9.  Simultaneous evaluation of brain tumour metabolism, structure and blood volume using [(18)F]-fluoroethyltyrosine (FET) PET/MRI: feasibility, agreement and initial experience.

Authors:  Otto M Henriksen; Vibeke A Larsen; Aida Muhic; Adam E Hansen; Henrik B W Larsson; Hans S Poulsen; Ian Law
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-09-12       Impact factor: 9.236

Review 10.  Optimal differentiation of high- and low-grade glioma and metastasis: a meta-analysis of perfusion, diffusion, and spectroscopy metrics.

Authors:  Jurgita Usinskiene; Agne Ulyte; Atle Bjørnerud; Jonas Venius; Vasileios K Katsaros; Ryte Rynkeviciene; Simona Letautiene; Darius Norkus; Kestutis Suziedelis; Saulius Rocka; Andrius Usinskas; Eduardas Aleknavicius
Journal:  Neuroradiology       Date:  2016-01-15       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.